A Study to Test Safety and Efficacy of Baricitinib in Participants With Diabetic Kidney Disease

NCT01683409 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

130

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Kidney Disease

Interventions

DRUG: Baricitinib
DRUG: Placebo

Sponsor

Eli Lilly and Company

Collaborators

[object Object]